However, the fraction of melanoma cases with underlying inherited predisposition by alterations in these genes is relatively low compared to CDKN2A, and in about 50% of familial cases of malignant melanoma, the underlying cause remains unexplained. This evidence concerns the gene CDKN2A and melanoma.